Study to Identify if Saie Beauty's Under Eye Concealer Works to Improve Under-Eye Skin Appearance and Reduce Imperfections

May 4, 2022 updated by: Saie Beauty
Saie Beauty has developed 'Hydrabeam Sheer Brightening Under Eye Concealer' that is specifically designed for improving under-eye skin health. The concealer is aimed at improving under-eye skin features including hydration, firmness/elasticity, smoothness, and brightness. At the same time, it is aimed at reducing imperfections such as dark circles, skin redness, fine lines, wrinkles, and crow's feet. The aim is to understand and assess the efficacy of treatment from the participants' perspective and to see if the participants reported changes in skin features, dark circles, brightness, fine lines, wrinkles, crow's feet, and other skin imperfections.

Study Overview

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Santa Monica, California, United States, 90404
        • Citruslabs

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female between 18 and 45 years old
  • Must be in good general health
  • Want to improve under-eye skin health by improving skin hydration, firmness/elasticity, smoothness, and brightness
  • May have dark circles, fine lines, wrinkles, and crow's feet
  • Must be willing to comply with the study protocol
  • Must be willing to add the concealer to their daily routine for the duration of the study
  • Must maintain a basic skincare routine, e.g., must use moisturizer and sunscreen daily
  • Able to communicate in English
  • Must provide a written Informed Consent Form (ICF)
  • Willing to share feedback via the given online portal

Exclusion Criteria:

  • Unwilling to follow the routine of the study
  • Unwilling to provide informed consent
  • Currently participating in another research study
  • Severe chronic conditions including ontological and psychiatric conditions
  • Use of prescription medication relevant for the skin
  • Have any known allergies to the ingredients of the test product
  • Known to have any severe allergic reactions in the past
  • Undergoing any cosmetic procedures such as laser treatments, Botox, or chemical peels for the duration of the study.
  • Have diagnosed or self-identified sensitive skin
  • Have any learning and/or cognitive difficulties that prevent them from reading and understanding questionnaires and surveys (e.g. dementia)
  • Currently pregnant or breastfeeding, or want to become pregnant for the duration of the study
  • Use of prescription drugs (topical or oral) that are targeted at any sort of skin condition (for example retinoids)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Eye Concealer
Saie Beauty's Hydrabeam Sheer Brightening Under Eye Concealer
Eye Concealer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skin aging [Time frame: Baseline to 4 weeks]
Time Frame: 4 weeks
Patient reported outcome measures (Scale 0-5 with higher scores representing a better outcome) to assess the reduction of early signs of aging such as fine lines, dark spots, and brighter skin
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 15, 2022

Primary Completion (ACTUAL)

May 1, 2022

Study Completion (ACTUAL)

May 1, 2022

Study Registration Dates

First Submitted

January 31, 2022

First Submitted That Met QC Criteria

January 31, 2022

First Posted (ACTUAL)

February 9, 2022

Study Record Updates

Last Update Posted (ACTUAL)

May 6, 2022

Last Update Submitted That Met QC Criteria

May 4, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 20231Saie

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wrinkle

3
Subscribe